University of Calgary scientists. Credit: Fritzology.

A research team at the University of Calgary in Canada is developing a new tool to allow accurate and fast measurement of proteins and small molecules that can indicate brain injuries, including concussion.

The new handheld, smartphone-sized device will contain electrodes which can identify key biomarkers in the blood samples of patients, two hours after a suspected injury. It will only require a small amount of blood to conduct the test.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“We need a more precise and accurate way to detect concussion, as well as a way to predict recovery.”

This polyethylenimine modified graphene-oxide electrochemical immunosensor leverages microfluidic technology to automate the sensing protocol.

It is claimed to be at least 100 times more sensitive compared to other brain injury biomarker approaches that are being currently tested.

The researchers expect the tool to address the unmet diagnostic needs in clinics with limited resources, rural health-care setups, a lack of emergency vehicles and those affected by war.

In addition, the device is said to have the potential to enable priority-based injury diagnosis in clinics, while delivering primary interventions, injury assessment and prognosis in hospitals.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

University of Calgary Cumming School of Medicine clinical assistant professor Chantel Debert said: “It would aid in diagnosing and determining outcomes, helping to ensure patients get their injury assessed quickly, and their total recovery monitored accurately.

“Currently concussion is diagnosed based on clinical judgment, which is subject to interpretation. We need a more precise and accurate way to detect concussion, as well as a way to predict recovery.”

Being developed under the university’s Integrated Concussion Research Program (ICRP), the diagnostic tool is ready to be advanced into clinical trials.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact